CO2RE Intima: What This Laser Is and What the Evidence Says

After childbirth or around menopause, you may notice vaginal dryness, burning, discomfort during sex or urine leakage when you cough. A search for solutions may lead to CO2RE Intima and promises of “non-surgical intimate rejuvenation”. The distinction matters: CO2RE Intima is a gynaecological module and applicators for the fractional CO₂ laser platform CO2RE. Its existence does not establish that it reliably treats all those symptoms. Before considering a laser, find out what is causing the problem and compare it with treatments supported by stronger clinical evidence.

This technology is not a substitute for a gynaecological examination or a required step to “restore” intimate tissue. Normal vulval anatomy, appearance and sensation vary between women. If you have no discomfort, there is no need to meet somebody else's idea of “tightness”. If symptoms affect your life, there are medical options that do not involve cosmetic procedures.

What is CO2RE Intima, and what does it do to tissue?

CO2RE is a carbon-dioxide laser platform associated with Candela (formerly Syneron-Candela). Intima refers to a gynaecological module and specialised handpieces designed for selected areas: external genital tissue, the vaginal opening and, according to the device configuration and indication, the vaginal canal. Fractional treatment creates multiple tiny zones of heat injury with relatively unaffected tissue between them. It is controlled thermal injury, not “cool rejuvenation”, that initiates healing responses.

Different CO2RE modes have different purposes: in surgery, lasers may cut, remove or coagulate tissue. That is different from proving effectiveness for dryness, incontinence or sexual dysfunction. The product name, regulatory documentation and permission to use it for a particular complaint are three separate questions. Marketing descriptions about “stimulating collagen” do not guarantee that your symptoms will improve or that any effect will last.

What do research and device authorisations actually show?

In the United States, the CO2RE system received FDA 510(k) clearance for certain surgical applications, including specified gynaecological soft-tissue procedures. This does not mean it was cleared as a treatment for genitourinary syndrome of menopause, urinary leakage or sexual problems. As ACOG explains, the FDA has not approved energy-based procedures for cosmetic “vaginal rejuvenation” or these symptom claims. Surgical indications must not be translated into promises of “tightening”, more sensation or “turning back time”.

Country-specific authorisation also matters. In 2020 Candela announced Health Canada approval of two gynaecological indications for the CO2RE platform: genitourinary syndrome of menopause and stress urinary incontinence. That is a manufacturer's announcement about Canada, not evidence of the same status in the US, Armenia or elsewhere, nor a guarantee of clinical benefit. In April 2026 Australia's TGA reported insufficient evidence of therapeutic benefit and long-term safety for devices marketed for vaginal rejuvenation, and said none remained listed for that intended use in Australia. Check the current national documentation for the actual device, applicators and proposed indication.

Some participants in fractional CO₂ laser studies reported less dryness or discomfort, but uncontrolled studies may overstate benefits. In a 2021 JAMA randomised sham-controlled study, fractional CO₂ laser did not show a convincing advantage over sham treatment for postmenopausal vaginal symptoms at 12 months. A 2025 systematic review of controlled and prospective evidence found little or no difference for several symptoms versus sham, with low-certainty evidence and limited harms reporting; its literature search covered studies through December 2023. The 2025 AUA/SUFU/AUGS guideline states that evidence does not support CO₂ laser or other energy-based methods for treating symptoms of genitourinary syndrome of menopause. Outside clinical trials, these approaches are regarded as experimental; through shared decision-making, a clinician may consider CO₂ laser for someone who is not a candidate for approved treatments or prefers an alternative, provided that uncertainty is explained. These studies involved different devices and settings: they cannot establish device-specific benefit for CO2RE Intima, and they do not mean every possible setting has been studied equally.

Concern	What can reasonably be said	Practical next step
Dryness, burning or pain after menopause	Early studies were encouraging, but higher-quality comparisons with sham have not established a sustained advantage for laser treatment	Evaluate genitourinary syndrome of menopause and discuss better-supported therapies first
Urine leakage with coughing or jumping	Evidence is insufficient to recommend routine laser treatment	Identify the incontinence type and begin appropriate conservative care
“Looseness” or altered sensations after childbirth	This is not a single diagnosis; muscles, scars, hormones and pelvic-floor function may all contribute	Identify the cause; laser is not a substitute for pelvic-floor care
Vulval appearance	Normal anatomy varies; a cosmetic concern is not automatically a disease	Define the actual aim and discuss realistic outcomes and tissue-injury risks

Which symptoms call for an examination rather than a laser?

Dryness and pain during sex may be related to lower oestrogen levels, but irritating skincare, infection, vulval skin disorders, pelvic-floor muscle spasm and other causes are also possible. Do not label burning as “age-related atrophy” without examination. Colour changes, fissures, ulcers, unusual discharge, unpleasant odour or new localised pain require diagnosis; using a laser on an unexplained lesion could delay appropriate treatment.

With urinary symptoms, distinguish stress leakage during exertion from urgent urges and mixed incontinence; they have different mechanisms and treatment plans. After birth, consider healing time, stitches, breastfeeding, muscle function and pelvic-organ support. A bulge, pressure or incomplete bladder emptying merits assessment for possible pelvic organ prolapse rather than an offer to “strengthen the walls” with a laser.

Bleeding after menopause, unexplained bleeding after sex, severe pelvic pain, fever or infection symptoms are not reasons to look for an aesthetic treatment. Contact a gynaecologist promptly; seek emergency care if severely unwell. Only after the diagnosis is clear is it sensible to ask whether any energy-based treatment has a role at all.

What should a consultation and possible session involve?

A thoughtful consultation begins with your own account of what is wrong, when it began, what you have tried and what you hope will change. Your clinician asks about menopause, childbirth, breastfeeding, medicines, infections, skin conditions and previous procedures. An examination and tests may be appropriate. Offering an intimate laser solely because of your age or an external-area photograph is a poor basis for consent.

If CO2RE Intima is still being considered after assessment, your clinician should say whether the external skin, vaginal opening or internal tissue will be treated. Sensations, anaesthesia, risks and restrictions differ. An internal applicator may be used for internal procedures; external treatment may use a different mode and local anaesthetic when needed. No single promise of “quick and completely painless” fits everyone. If dryness is severe, even inserting an applicator may be uncomfortable.

Before any intervention, discuss pregnancy, infection, unexplained bleeding, unhealed injuries, impaired wound healing and any contraindications listed for the precise system used. Elective cosmetic treatment in pregnancy or with active inflammation should not proceed without proper clinical evaluation. During breastfeeding, after birth or while receiving cancer treatment, decisions require individual assessment by the appropriate specialist. Your consent to an intimate examination, the ability to stop at any time and your right to decline the presence of observers also matter.

What does recovery mean for work, intimacy and daily life?

A difficult aspect is that you might look completely normal while mucosal tissue remains irritated. Temporary burning, soreness, swelling, sensitivity, discharge and light spotting have been described after energy-based treatment. External application may leave visible redness; symptoms from internal treatment are invisible to others. “No social downtime” therefore does not mean that tissue has healed medically.

Restrictions on sex, tampons, exercise, baths and swimming must be based on the device-specific instructions, treatment depth and clinical findings, not a generic promotional calendar. Some protocols require a period without penetrative sex, but that interval cannot be transferred between devices or settings. If intimacy, travel or strenuous activity is important in the following days, discuss this first and be ready to postpone an optional procedure.

The clinician should provide written aftercare instructions, describe expected discharge, explain pain relief and give a direct contact for complications. Do not insert harsh antiseptics, acids or cosmetic products into the vagina in an attempt to speed healing. Severe or worsening pain, substantial bleeding, fever, foul-smelling discharge, difficulty passing urine or an unusual wound needs urgent medical assessment.

Which risks and unknowns are hidden by “non-invasive”?

A CO₂ laser injures tissue through heat even when there is no scalpel incision. The FDA and ACOG have warned about burns, scarring, pain during sex and lasting pain with energy-based “vaginal rejuvenation”. Infection and worsening of pre-existing discomfort are also possible. The frequency of serious problems for any particular CO2RE Intima protocol is not reliably established: a small series with no serious events cannot prove safety for everyone.

The risk is not only physical injury. You might spend money on a procedure that does not address the underlying pain or urine leakage and delay better-supported care. Promises of better orgasms, “restored virginity” or guaranteed vaginal narrowing deserve particular scepticism: such goals are misleading or unsupported. Choosing not to proceed is not the same as neglecting your health.

What alternatives deserve attention before CO2RE Intima?

For genitourinary syndrome of menopause, regular vaginal moisturisers and lubricants for sex are often useful initial options. Where appropriate, a clinician can discuss low-dose local vaginal oestrogen or other medicines with your medical history and contraindications in mind. Cancer-related circumstances or concerns about hormones require coordinated specialist advice, not an automatic switch to laser treatment.

For stress incontinence, initial care often includes supervised pelvic-floor muscle training, reducing aggravating factors and a personalised treatment plan. For painful sex, identifying the cause, pelvic-floor therapy, treatment for skin conditions and suitable lubricants may help. For prolapse, options can include monitoring, a pessary or surgery where necessary. These choices are not inferior merely because laser devices look newer in advertisements.

If you are comparing FemiLift, Votiva or other energy-based intimate devices, do not focus only on the brand list. Compare the energy type, specific intended use, controlled evidence and plan for managing complications. Radiofrequency systems and fractional CO₂ lasers do not automatically have the same settings or risks. Seek a gynaecologist experienced in your actual problem; pelvic-floor disorders may require a related specialist.

Which questions help you keep control of the decision?

What exactly is my diagnosis, how was it confirmed and why is this tissue being targeted?
Which device, module and applicator will be used, and what authorisation applies to this country and intended use?
Are there good studies for my symptom, including comparisons with sham treatment or standard care?
What are the worst realistic complications, how would they be recognised and whom can I contact at night or over a weekend?
What happens if it does not help, including possible additional costs and repeat procedures?
What less invasive choices exist, and what happens if I decide to do nothing for now?

If the answers consist only of “innovative”, “completely safe” and “suitable for everyone”, that is enough reason to get a second opinion. Success in intimate health is measured by relief of a specific, properly assessed symptom without unacceptable harm—and by your own informed, voluntary choice, not by a photograph or the word “rejuvenation”.

Additional questions

Should I have laser treatment preventively if I have no symptoms?

There is no evidence justifying preventive CO2RE Intima treatment of healthy tissue. Without symptoms and a specific medical indication, the procedure is unnecessary.

Can a friend’s positive experience tell me whether it will help?

Her experience matters to her but does not prove that the device caused the improvement. Symptoms, diagnoses, settings and simultaneous therapies may differ; controlled research on your condition is more informative.

Who should hear about an adverse effect besides my doctor?

First seek examination and have the event documented. Ask your doctor or national regulator how to report a medical-device adverse event; reporting channels differ by country.